267 results
8-K
SEEL
Seelos Therapeutics Inc
16 May 24
Material Modifications to Rights of Security Holders
9:00am
for issuance under the Company’s equity incentive plans will be proportionately adjusted for the Reverse Stock Split ratio, such that fewer shares
8-K
EX-99.1
SEEL
Seelos Therapeutics Inc
14 May 24
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
11:45am
and under the Company’s equity incentive plans, as applicable.
The reverse stock split will reduce the number of issued and outstanding shares
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
Disease Designation (“RPDD”) for SLS-005 in Sanfilippo Syndrome from the FDA. RPDD is an incentive program created under the Federal Food, Drug … during fiscal year 2023 (the “Named Executive Officers”):
Name and Position(s)
Year
Salary
Option
Awards(1)
Non-Equity
Incentive
Plan
Compensation
All
S-8
094 j6xxq
6 Mar 24
Registration of securities for employees
5:38pm
S-8
EX-5.1
yonzndezjnflncqkjt
6 Mar 24
Registration of securities for employees
5:38pm
S-8
bgb1w74nx u2yo
6 Mar 24
Registration of securities for employees
5:38pm
424B5
jqblnm oqts
30 Jan 24
Prospectus supplement for primary offering
6:05am
DEFA14A
485 icrhx
22 Dec 23
Additional proxy soliciting materials
4:01pm
424B5
beq6ojw0 342xqfe7m
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
h2mjbfb68eyi ff
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
ezu 9yj8r0bk
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am